Literature DB >> 15284443

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.

George Adrian Calin1, Chang-Gong Liu, Cinzia Sevignani, Manuela Ferracin, Nadia Felli, Calin Dan Dumitru, Masayoshi Shimizu, Amelia Cimmino, Simona Zupo, Mariella Dono, Marie L Dell'Aquila, Hansjuerg Alder, Laura Rassenti, Thomas J Kipps, Florencia Bullrich, Massimo Negrini, Carlo M Croce.   

Abstract

Little is known about the expression levels or function of micro-RNAs (miRNAs) in normal and neoplastic cells, although it is becoming clear that miRNAs play important roles in the regulation of gene expression during development [Ambros, V. (2003) Cell 113, 673-676; McManus, M. T. (2003) Semin. Cancer Biol. 13, 253-258]. We now report the genomewide expression profiling of miRNAs in human B cell chronic lymphocytic leukemia (CLL) by using a microarray containing hundreds of human precursor and mature miRNA oligonucleotide probes. This approach allowed us to identify significant differences in miRNome expression between CLL samples and normal CD5+ B cells; data were confirmed by Northern blot analyses and real-time RT-PCR. At least two distinct clusters of CLL samples can be identified that were associated with the presence or absence of Zap-70 expression, a predictor of early disease progression. Two miRNA signatures were associated with the presence or absence of mutations in the expressed Ig variableregion genes or with deletions at 13q14, respectively. These data suggest that miRNA expression patterns have relevance to the biological and clinical behavior of this leukemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284443      PMCID: PMC511048          DOI: 10.1073/pnas.0404432101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

2.  ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.

Authors:  Jenny A Orchard; Rachel E Ibbotson; Zadie Davis; Adrian Wiestner; Andreas Rosenwald; Peter W Thomas; Terry J Hamblin; Louis M Staudt; David G Oscier
Journal:  Lancet       Date:  2004-01-10       Impact factor: 79.321

3.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

4.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

5.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

6.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

7.  Computational identification of microRNA targets.

Authors:  Nikolaus Rajewsky; Nicholas D Socci
Journal:  Dev Biol       Date:  2004-03-15       Impact factor: 3.582

8.  Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma.

Authors:  Akinobu Ota; Hiroyuki Tagawa; Sivasundaram Karnan; Shinobu Tsuzuki; Abraham Karpas; Shigeki Kira; Yasuko Yoshida; Masao Seto
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

9.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

10.  MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status.

Authors:  H M Müller; H Fiegl; G Goebel; M M Hubalek; A Widschwendter; E Müller-Holzner; C Marth; M Widschwendter
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

View more
  452 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.

Authors:  Rosa Visone; Angelo Veronese; Laura Z Rassenti; Veronica Balatti; Dennis K Pearl; Mario Acunzo; Stefano Volinia; Cristian Taccioli; Thomas J Kipps; Carlo M Croce
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

3.  MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.

Authors:  Hao Fu; Hui-chan He; Zhao-dong Han; Yue-ping Wan; Hong-wei Luo; Ya-qiang Huang; Chao Cai; Yu-xiang Liang; Qi-shan Dai; Fu-neng Jiang; Wei-de Zhong
Journal:  Tumour Biol       Date:  2014-11-15

4.  Influence of RNA labeling on expression profiling of microRNAs.

Authors:  John S Kaddis; Daniel H Wai; Jessica Bowers; Nicole Hartmann; Lukas Baeriswyl; Sheetal Bajaj; Michael J Anderson; Robert C Getts; Timothy J Triche
Journal:  J Mol Diagn       Date:  2011-11-07       Impact factor: 5.568

Review 5.  MicroRNAs are shaping the hematopoietic landscape.

Authors:  Ute Bissels; Andreas Bosio; Wolfgang Wagner
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

6.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

Review 7.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

Authors:  John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson
Journal:  J Mol Biol       Date:  2010-08-01       Impact factor: 5.469

8.  MicroRNA polymorphisms: a giant leap towards personalized medicine.

Authors:  Prasun J Mishra
Journal:  Per Med       Date:  2009-03-01       Impact factor: 2.512

9.  Regulation of adrenal and ovarian steroidogenesis by miR-132.

Authors:  Zhigang Hu; Wen-Jun Shen; Fredric B Kraemer; Salman Azhar
Journal:  J Mol Endocrinol       Date:  2017-07-20       Impact factor: 5.098

10.  microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.

Authors:  Aldo M Roccaro; Antonio Sacco; Changzhong Chen; Judith Runnels; Xavier Leleu; Feda Azab; Abdel Kareem Azab; Xiaoying Jia; Hai T Ngo; Molly R Melhem; Nicholas Burwick; Lyuba Varticovski; Carl D Novina; Barrett J Rollins; Kenneth C Anderson; Irene M Ghobrial
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.